Association of Serum Biomarker Levels and BDNF Gene Polymorphism with Response to Selective Serotonin Reuptake Inhibitors in Indian Patients with Major Depressive Disorder
- 30 July 2020
- journal article
- research article
- Published by S. Karger AG in Neuropsychobiology
- Vol. 80 (3), 201-213
- https://doi.org/10.1159/000507371
Abstract
Introduction: Depression is a major public health problem. Response to selective serotonin reuptake inhibitor (SSRI) treatment varies considerably between patients. In the context of polygenic diseases like depression, measurement of a panel of biomarkers involved in the pathophysiology of depression might help predict outcome to treatment with SSRIs. Objective: The objective was to establish the relationship between serum biomarker levels and the brain-derived neurotrophic factor (BDNF) val66met polymorphism and response to SSRIs in patients with major depressive disorder. Methods: 50 patients with moderate to severe depression were recruited from the Department of Psychiatry, Sri Ramachandra Institute of Higher Education and Research. Blood samples were collected, and Hamilton Depression Rating Scale scoring was done at baseline and after 8 weeks of treatment with SSRIs. Baseline and post-treatment levels of high-sensitivity C-reactive protein (hsCRP), BDNF and neuregulin 1β1 (NRG1β1) were analysed using commercially available ELISA kits. Genotyping of the BDNF Val66Met polymorphism was performed using a PCR-RFLP method. Results: Following treatment, there was a significant decrease in the mean hsCRP and NRG1β1 levels and a significant increase in the mean BDNF level. Responders had significantly lower baseline hsCRP and higher baseline BDNF levels when compared to non-responders. Response rates were significantly higher in the Val/Val group when compared to the Val/Met group. Conclusions: Baseline serum levels of hsCRP and BDNF predicted response to SSRIs in major depressive disorder, and Val/Val patients responded better when compared to patients carrying the Met allele.Keywords
This publication has 70 references indexed in Scilit:
- BDNF Val66Met Impairs Fluoxetine-Induced Enhancement of Adult Hippocampus PlasticityNeuropsychopharmacology, 2012
- BDNF Val66met polymorphism, white matter abnormalities and remission of geriatric depressionJournal of Affective Disorders, 2010
- An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer CellsCancer Cell, 2010
- Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interfaceBrain, Behavior, and Immunity, 2009
- Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implicationsBiological Psychiatry, 2008
- Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant ReversalBiological Psychiatry, 2008
- TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive TreatmentNeuron, 2008
- Peripheral Inflammation is Associated with Altered Substantia Nigra Activity and Psychomotor Slowing in HumansBiological Psychiatry, 2008
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant EfficacyBiological Psychiatry, 2008
- Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effectsProceedings of the National Academy of Sciences of the United States of America, 2006